Pharmacokinetics and Safety of Spesolimab in Healthy Chinese Subjects: An Open-Label, Phase I Study.
Guoying CaoHaijing YangJingjing WangMasahiro IshidaChristian ThomaThomas HaeufelSebastian BossertWanzhen LiPublished in: Advances in therapy (2024)
Clinicaltrials.gov registration: NCT04390568.
Keyphrases